METASTATIC NSCLC
Clinical trials for METASTATIC NSCLC explained in plain language.
Never miss a new study
Get alerted when new METASTATIC NSCLC trials appear
Sign up with your email to follow new studies for METASTATIC NSCLC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Nanoparticle 'Booster' trial aims to supercharge cancer treatment
Disease control OngoingThis early-stage trial is testing whether injecting a nanoparticle called NBTXR3 directly into a tumor, then activating it with radiation, can make immunotherapy work better for people with advanced cancers. The study will enroll about 145 patients with various cancers that have …
Matched conditions: METASTATIC NSCLC
Phase: PHASE1 • Sponsor: Nanobiotix • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New copycat cancer drug enters final testing phase
Disease control TerminatedThis study compares a new biosimilar version of the cancer drug pembrolizumab (Keytruda) to the original drug in adults with untreated metastatic non-small cell lung cancer. Participants receive either the new biosimilar or the established drug, both combined with chemotherapy, t…
Matched conditions: METASTATIC NSCLC
Phase: PHASE3 • Sponsor: Sandoz • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
Blood test may reveal who wins the cancer fight
Knowledge-focused OngoingThis study aims to find a better way to predict which patients with advanced lung or head and neck cancer will respond to immunotherapy. Researchers will collect blood samples from 75 patients before and during their standard immunotherapy treatment. They will measure how quickly…
Matched conditions: METASTATIC NSCLC
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Apr 01, 2026 23:55 UTC